KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Guardant Health (GH) Equity Average (2018 - 2025)

Guardant Health's Equity Average history spans 8 years, with the latest figure at -$226.9 million for Q4 2025.

  • For Q4 2025, Equity Average fell 127.18% year-over-year to -$226.9 million; the TTM value through Dec 2025 reached -$226.9 million, down 127.18%, while the annual FY2025 figure was -$119.5 million, 1355.21% down from the prior year.
  • Equity Average for Q4 2025 was -$226.9 million at Guardant Health, up from -$330.0 million in the prior quarter.
  • Across five years, Equity Average topped out at $1.1 billion in Q1 2021 and bottomed at -$330.0 million in Q3 2025.
  • The 5-year median for Equity Average is $118.8 million (2023), against an average of $213.0 million.
  • The largest annual shift saw Equity Average surged 1352.23% in 2024 before it plummeted 969.45% in 2025.
  • A 5-year view of Equity Average shows it stood at $677.2 million in 2021, then plummeted by 83.25% to $113.5 million in 2022, then surged by 70.53% to $193.5 million in 2023, then crashed by 151.62% to -$99.9 million in 2024, then plummeted by 127.18% to -$226.9 million in 2025.
  • Per Business Quant, the three most recent readings for GH's Equity Average are -$226.9 million (Q4 2025), -$330.0 million (Q3 2025), and -$278.1 million (Q2 2025).